These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4362322)

  • 1. Immunological activity of foot-and-mouth disease virus purified by polyethylene glycol precipitation.
    Panina GF; de Simone F
    Zentralbl Veterinarmed B; 1973 Dec; 20(10):773-82. PubMed ID: 4362322
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunochemical studies of foot-and-mouth disease. VII. Characterization of foot-and-mouth disease virus concentrated by polyethylene glycol precipitation.
    Wagner GG; Card JL; Cowan KM
    Arch Gesamte Virusforsch; 1970; 30(4):343-52. PubMed ID: 4318624
    [No Abstract]   [Full Text] [Related]  

  • 3. [Concentration of foot-and-mouth disease virus by polyethylene glycol].
    Fayet MT
    Ann Inst Pasteur (Paris); 1970 Mar; 118(3):356-66. PubMed ID: 4315858
    [No Abstract]   [Full Text] [Related]  

  • 4. Indirect complement fixation test with foot-and-mouth disease virus antigen concentrated by polyethylene glycol precipitation.
    Sakaki K; Suphavilai P; Kongthon S
    Natl Inst Anim Health Q (Tokyo); 1978; 18(1):8-17. PubMed ID: 206842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foot-and-mouth disease virus in cattle and pigs: use of polyethylene glycol or dextran for purifying 19S gamma-M immunoglobulin from sera.
    Warrington RE; Morgan DO
    Arch Gesamte Virusforsch; 1971; 33(1):134-44. PubMed ID: 4325971
    [No Abstract]   [Full Text] [Related]  

  • 6. A simple method for the quantification of 140S particles of foot-and-mouth disease virus (FMDV).
    Barteling SJ; Meloen RH
    Arch Gesamte Virusforsch; 1974; 45(4):362-4. PubMed ID: 4374160
    [No Abstract]   [Full Text] [Related]  

  • 7. Concentration and purification of foot-and-mouth disease (FMD) virus by polyethylenglycol (PEG).
    Kaaden OR; Dietzschold B; Matheka HD; Tokui T
    Arch Gesamte Virusforsch; 1971; 35(1):104-13. PubMed ID: 4331777
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antigenic properties of the foot-and-mouth disease virus concentrated by polyethylene glycol].
    Sobko AI; Prokhorov VN; Sokolov LN; Koshetsian EG
    Veterinariia; 1973 May; 49(5):67-8. PubMed ID: 4353691
    [No Abstract]   [Full Text] [Related]  

  • 9. The aerosol stability of a strain of foot-and-mouth disease virus and the effects on stability of precipitation with ammonium sulphate, methanol or polyethylene glycol.
    Barlow DF
    J Gen Virol; 1972 Apr; 15(1):17-24. PubMed ID: 4337216
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of an effective vaccine against foot-and-mouth disease with partially purified and concentrated virus antigen.
    Sen AK; Saha SN
    Acta Virol; 1994 Feb; 38(1):17-9. PubMed ID: 8067308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quantitative studies of ammonium sulfate precipitation of foot-and-mouth disease virus].
    Liebermann H; Hantschel H; Pick C
    Arch Exp Veterinarmed; 1987 Nov; 41(6):812-6. PubMed ID: 2831829
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experiments to purify and concentrate the foot-and-mouth disease virus].
    Tekerlekov P; Popov G; Vasileva L; Nikolova E
    Vet Med Nauki; 1985; 22(10):3-9. PubMed ID: 3004012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Foot-and-mouth disease in Ethiopia. Distribution of serotypes of foot-and-mouth disease virus].
    Martel JL
    Rev Elev Med Vet Pays Trop; 1974; 27(2):169-75. PubMed ID: 4377719
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of polyethyleneglycol-treated serum for animal cell cultures.
    Barteling SJ
    Dev Biol Stand; 1976 Dec 13-15; 37():91-5. PubMed ID: 201528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential precipitation of foot and mouth disease virus proteins made in vivo and in vitro by hyperimmune and virus particle guinea pig antisera.
    Harris TJ; Brown F; Sangar DV
    Virology; 1981 Jul; 112(1):91-8. PubMed ID: 6264693
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparatve serological and immunological study of strains of foot-and-mouth disease virus type "O" isolated in Europe between 1963 and 1966].
    Moosbrugger GA; Leunen J; Mackowiak C; Fontaine J; Roumiantzeff M
    Bull Off Int Epizoot; 1967; 67(5):711-29. PubMed ID: 4303616
    [No Abstract]   [Full Text] [Related]  

  • 17. [Influence of temperature on complement fixation activity of the foot-and-mouth disease virus].
    Petr G; Láznicka F
    Vet Med (Praha); 1971 Dec; 16(11):689-96. PubMed ID: 4336298
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of three 'ready to formulate' oil adjuvants for foot-and-mouth disease vaccine production.
    Iyer AV; Ghosh S; Singh SN; Deshmukh RA
    Vaccine; 2000 Dec; 19(9-10):1097-105. PubMed ID: 11137244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of purified foot and mouth disease virus after freeze-drying and storage.
    Fellowes ON
    Cryobiology; 1968; 5(3):234-7. PubMed ID: 4304872
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antigenic properties of strains of A 22 foot-and-mouth disease virus isolated in epizootic conditions].
    Salajov EL; Antoniouk VP
    Bull Off Int Epizoot; 1972; 77(5):929-34. PubMed ID: 4350008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.